Clinical Trials & Research

Sertraline, an antidepressant that doctors commonly prescribe, appears to work by reducing anxiety first and doesn’t start tackling depressive symptoms until weeks later. New research sheds fresh light on how antidepressants work. This was the main finding of a study on the use of antidepressants in primary care settings in the United Kingdom. The researchers
0 Comments
An open-label clinical trial working with eight people with Alzheimer’s disease concluded that a new wearable device that emits electromagnetic impulses was able to significantly improve memory loss in seven of these participants within 2 months. An innovative wearable device can significantly reduce memory loss in Alzheimer’s disease, according to a new clinical trial. Alzheimer’s
0 Comments
Millions of people around the world have obsessive-compulsive disorder (OCD), a condition that often has a significant impact on well-being and quality of life. New research from Israel outlines a new therapy option that could help people with OCD that does not respond to other treatments. Can magnetic stimulation work where other treatment options do
0 Comments
Researchers from the United Kingdom have appraised the most recent assessment by the European Food Safety Authority regarding the safety of aspartame, a popular type of artificial sweetener. The investigators caution that the commission’s findings may be misleading. Is aspartame really as safe as official reports claim? Some researchers are unsure. Aspartame is perhaps the
0 Comments
A new drug for treating Alzheimer’s disease has successfully passed the first phase of testing in humans. Preclinical studies had already shown that the drug could improve memory and other symptoms of Alzheimer’s disease in older mice. A potential treatment for Alzheimer’s moves a step closer. Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf,
0 Comments
Laboratory and animal studies have suggested that the leukemia drug nilotinib could alleviate symptoms of Parkinson’s disease. Now, using early results from a clinical trial in humans, scientists have worked out how the drug reduces toxic protein and raises dopamine levels in the brain. New research explains how a cancer drug increases levels of the
0 Comments